India Approves Dengue Vaccine for 4-60 Years

Regulatory Approval and Vaccine Specifications

The Central Drugs Standard Control Organisation has granted marketing authorisation for Qdenga, India’s first approved dengue vaccine, for individuals aged 4 to 60. Developed by Takeda, the two-dose, live-attenuated vaccine provides